Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapy

Miller, J. E., Taylor‐Cousar, J. L., Overdevest, J. B., Khatiwada, A., Mace, J. C., Alt, J. A., Bodner, T. E., Chowdhury, N. I., DiMango, E. A., Eshaghian, P. H., Getz, A. E., Gudis, D. A., Han, E. J., Hwang, P. H., Keating, C. L., Khanwalkar, A., Kimple, A. J., Lee, J. T., Li, D., … Beswick, D. M. (2023). Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapy. International Forum of Allergy & Rhinology, 14(6), 1079–1087. Portico. https://doi.org/10.1002/alr.23312
Authors:
Jessa E Miller
Jennifer L Taylor-Cousar
Jonathan B Overdevest
Aastha Khatiwada
Jess C Mace
Jeremiah A Alt
Todd E Bodner
Naweed I Chowdhury
Emily A DiMango
Patricia H Eshaghian
Anne E Getz
David A Gudis
Ethan J Han
Peter H Hwang
Claire L Keating
Ashoke Khanwalkar
Adam J Kimple
Jivianne T Lee
Douglas Li
Karolin Markarian
Meghan Norris
Jayakar V Nayak
Cameran Owens
Zara M Patel
Katie Poch
Rodney J Schlosser
Kristine A Smith
Timothy L Smith
Zachary M Soler
Jeffrey D Suh
Jeremy P Tervo
Grant A Turner
Marilene B Wang
Milene T Saavedra
Daniel M Beswick
Affiliated Authors:
Jonathan B Overdevest
Emily A DiMango
David A Gudis
Claire L Keating
Jeremy P Tervo
Author Keywords:
chronic rhinosinusitis
cystic fibrosis
highly effective modulator therapy
olfaction
olfactory disorders
olfactory dysfunction
olfactory test
patient-reported outcome measure
quality of life
patient‐reported outcome measure
Publication Type:
Article
Unique ID:
10.1002/alr.23312
PMID:
Publication Date:
Data Source:
PubMed

Record Created: